CIDP - Centre International de Développement Pharmaceutique
Claire Blazy-Jauzac started their work experience in 2003 as a Project Manager in the department of Investigational Product at sanofi-aventis. In 2005, they joined CIDP - Centre International de Développement Pharmaceutique, where they held various roles, including Quality Assurance Manager from 2005 to 2009, Group Managing Director from 2009 to 2016, Deputy Chief Executive Officer from 2016 to 2018, and currently the Group CEO since July 2018.
Claire Blazy-Jauzac has a strong educational background with a focus on pharmacy and management. Claire completed a PhD in Pharmacy (Pharm D) from the Faculty of Pharmacy in Toulouse, France, from 1996 to 2003. Additionally, they pursued a Masters degree in Pharmaceutical Control and Manufacturing from the same institution from 2001 to 2002.
In terms of further professional development, Claire obtained several certifications. Claire completed ICH GCP training from Whitehall Training in May 2021. In March 2007, they obtained certification as an Internal Auditor from the Gestion and Support Training Centre. Furthermore, in June 2005, they received certification in Audit in Clinical Research and Development from CEFIRA.
Overall, Claire's educational journey showcases their commitment to advancing their knowledge and expertise in the fields of pharmacy, management, and clinical research.
This person is not in any offices
CIDP - Centre International de Développement Pharmaceutique
CIDP, Naturally Innovative Established in 2004, CIDP is a private and independent Contract Research Organisation (CRO) that carries out high-performance R&D activities. With over 17 years of experience in the clinical research, CIDP has a strong foothold on each continent with centres located in Brazil, India, Mauritius, and Romania offering an ideal platform for all your research projects worldwide. The services provided by CIDP are segmented into five main areas of expertise: Research & Development activities, Preclinical in vitro testing, Clinical research, Biostatistics and Data Management and Regulatory Affairs. CIDP comprises a team of 130 staff members: doctors, pharmacists, project managers, clinical research assistant, biostatisticians, biologists, chemists, data managers... and has built over the years an international network of investigators who are highly qualified in their different therapeutic fields. We also have developed an independent Global Quality Assurance department which monitors our studies worldwide. All of our subsidiaries are ISO 9001 certified. The modern and secured offices and the equipment reflect the high quality standard required for the successful conduct of clinical studies. Through its R&I cluster, the centre in Mauritius focuses its investigation on plants and their potential applications in the field of cosmetic, nutrition and therapy. Its geographical position at the heart of the Mascarenes Islands and proximity to the African continent gives it very enviable access to a rich and unexploited flora. From this unique biodiversity and CIDP’s cutting edge expertise in ethno-pharmacology and research, it aims to become a premium provider of novel phytochemicals, proprietary-based ingredient technologies and seamless contract research services on natural products.